Pernix Therapeutics Chooses Morristown, New Jersey, For New Corporate Headquarters
“Establishing Pernix’s headquarters in Morristown, New Jersey continues our efforts to build Pernix into a focused specialty pharmaceutical company with an experienced management team that is well-positioned for additional product acquisitions,” Doug Drysdale, President/CEO of Pernix said.
According to the firm, its new corporate headquarters will be occupied in mid-May “and is a key step towards the achievement of several corporate initiatives, including improving the efficiency of the Company’s operational infrastructure by consolidating office locations and hiring and retaining experienced employees.”
“ The Company has shifted its emphasis from horizontal integration to focusing on its core sales and marketing strengths to build a leading specialty pharmaceutical business,” company officials said.
The Company markets a portfolio of branded products, including: CEDAX, an antibiotic for middle ear infections and a number of treatments for cough and cold conditions including ZUTRIPRO, REZIRA and VITUZ. The Company also markets SILENOR, a non-narcotic product for the treatment of insomnia and KHEDEZLA, a treatment for major depressive disorder.
Germany-Based Fresenius Kabi Plans Regional Distribution Hub in Pleasant Prairie, Wisconsin
A Site Selector’s Checklist for Locating in the U.S.
Location USA 2019
2018 Top States for Doing Business: Georgia Ranks #1 Fifth Year in a Row
A Changing Food Manufacturing Industry
2017 Food Processing
2018 Leading Metro Locations: Pacific and Mountain Metros Dominate the List
33rd Annual Corporate Survey & the 15th Annual Consultants Survey
What Makes a Successful Innovation District?